glutamine and Chronic Progressive Multiple Sclerosis

glutamine has been researched along with Chronic Progressive Multiple Sclerosis in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Abdel-Aziz, K; Altmann, DR; Ciccarelli, O; Day, BL; Peters, AL; Schneider, T; Solanky, BS; Thompson, AJ; Wheeler-Kingshott, CA; Yiannakas, MC1
Freedman, MS; Kolind, SH; Li, DK; MacMillan, EL; Oger, J; Tam, R; Traboulsee, AL; Vavasour, IM; Zhao, Y1
Friedrich, MG; Hancock, SE; Raftery, MJ; Truscott, RJ1

Other Studies

3 other study(ies) available for glutamine and Chronic Progressive Multiple Sclerosis

ArticleYear
Evidence for early neurodegeneration in the cervical cord of patients with primary progressive multiple sclerosis.
    Brain : a journal of neurology, 2015, Volume: 138, Issue:Pt 6

    Topics: Adolescent; Adult; Aged; Aspartic Acid; Atrophy; Brain; Case-Control Studies; Cervical Cord; Disability Evaluation; Early Diagnosis; Female; Glutamic Acid; Glutamine; Gray Matter; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Sclerosis, Chronic Progressive; Nerve Degeneration; Proton Magnetic Resonance Spectroscopy; Spinal Cord; White Matter; Young Adult

2015
Progressive multiple sclerosis exhibits decreasing glutamate and glutamine over two years.
    Multiple sclerosis (Houndmills, Basingstoke, England), 2016, Volume: 22, Issue:1

    Topics: Adult; Aged; Biomarkers; Disease Progression; Female; Follow-Up Studies; Glutamic Acid; Glutamine; Humans; Magnetic Resonance Spectroscopy; Male; Middle Aged; Multiple Sclerosis, Chronic Progressive; Time Factors

2016
Isoaspartic acid is present at specific sites in myelin basic protein from multiple sclerosis patients: could this represent a trigger for disease onset?
    Acta neuropathologica communications, 2016, 08-12, Volume: 4, Issue:1

    Topics: Adult; Aged; Aging; Arginine; Aspartic Acid; Cerebellum; Glutamine; Humans; Isoaspartic Acid; Mass Spectrometry; Middle Aged; Models, Molecular; Multiple Sclerosis, Chronic Progressive; Multiple Sclerosis, Relapsing-Remitting; Myelin Basic Protein; Protein Processing, Post-Translational; Proteolysis

2016